Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.1616
Delayed Data
As of Dec 09
 +0.0013 / +0.81%
Today’s Change
0.14
Today|||52-Week Range
0.45
-55.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization7.6K6.2K8.9K9.1K
 
 
 
 
 
 
Operating ExpensesGross Income-7.6K-6.2K-8.9K-9.1K
 
 
 
 
 
General Expenses4.4M4.9M3.9M3.7M
 
 
 
 
 
Research And Development2.9M3.5M2.2M2.3M
 
 
 
 
 
Total Operating Expenses4.4M4.9M3.9M3.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.4M-4.9M-3.9M-3.7M
 
 
 
 
 
Extraordinary Credit1.7M856.0K2.1M967.6K
 
 
 
 
 
Other Expenses-211.1K-169.9K0.00-143.2K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.9M-4.1M-1.8M-2.9M
 
 
 
 
 
Net Income-2.9M-4.1M-1.8M-2.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS197.4M202.6M213.2M216.4M
 
 
 
 
 
Shares To Calculate EPS Diluted197.4M202.6M213.2M216.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.01-$0.01
 
 
 
 
 
EPS Diluted-$0.01-$0.02-$0.01-$0.01